Live Breaking News & Updates on Biocytogen Pharmaceuticals Biotech Company Antibody Therapeutics Myricx Bio Drug Conjugates Adcs Cytotoxic Payloads Renmice Dr Yuelei Shen Nmti Robin Carr Renmab Renlite Rennano

Biocytogen Pharmaceuticals a global biotech company focusing on the discovery of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Myricx Bio a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates ADCs. ....

City Of , United Kingdom , United States , San Francisco , Yuelei Shen , Robin Carr , Myricx Bio , Haimen Jiangsu , Integrum Renmice , Biocytogen Pharmaceuticals Beijing Co Ltd , Myricx Pharma , Francis Crick Institute , Imperial College London , Project Integrum , Sofinnova Partners , Brandon Capital , Media Contact , Biocytogen Pharmaceuticals Biotech Company Antibody Therapeutics Myricx Bio Drug Conjugates Adcs Cytotoxic Payloads Renmice Dr Yuelei Shen Nmti Robin Carr Renmab Renlite Rennano ,